U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 209184

Marketing Status: Prescription
Active Ingredient: LEVODOPA
Proprietary Name: INBRIJA
Dosage Form; Route of Administration: POWDER; INHALATION
Strength: 42MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N209184
Product Number: 001
Approval Date: Dec 21, 2018
Applicant Holder Full Name: ACORDA THERAPEUTICS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top